However, given CD56’s association with NK cell activity, crucial in immune surveillance and elimination of transformed cells, its low expression may reflect a less responsive microenvironment, potentially contributing to the tumor progression observed in subsequent weeks. This evidence concerns the gene NCAM1 and neoplasm.